CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Psychiatric counselingWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug2797 daily syndromic surveillance Wiki 1.00
drug2898 monthly serologic IgM/G test Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Psychiatric Consultation for COVID-19 Patients

In this study, the content and results of the psychiatric consultation on patients in Corona Care Ward were verified retroactively, and the effects of COVID-19 patients' emotional state and psychological support and crisis intervention were assessed on their emotional state. Patients who are admitted to the COVID-19 care unit of the Catholic University of Daegu Hospital are subject to consultation with the psychiatrist. By retrospectively reviewing the medical records of the request and the results of the subjects, We collected Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings, medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS, P4, SF-36, SCL-90-R) This study evaluates whether there is a difference in psychological scale according to differences in socio-demographic status and medical severity, and compares psychological measures before and after referral to mental health medicine to evaluate the effectiveness of psychiatric counseling.

NCT04395872 Covid19 Psychiatric Problem Isolation, Social Behavioral: Psychiatric counseling

Primary Outcomes

Description: for assess depressive symptom

Measure: Change of PHQ-9 (Patient Health Questionnaire-9)

Time: On admission and at the time of discharge, on average 2 months

Description: for assess anxiety symptom

Measure: Change of GAD-7 (Patient Health Questionnaire-9)

Time: On admission and at the time of discharge, on average 2 months

Description: for assess PTSD symptom

Measure: Change of PC-PTSD-5 (Primary Care PTSD Screen for DSM-5)

Time: On admission and at the time of discharge, on average 2 months

Description: for assess insomnia

Measure: Change of AIS (Athens Insomnia Scale)

Time: On admission and at the time of discharge, on average 2 months

Description: for assess suicidal idea

Measure: Change of P4 (P4 Suicidality Screener)

Time: On admission and at the time of discharge, on average 2 months

Description: for assess health associated QoL

Measure: Change of SF-36 (Short Form Health Survey Questionnaire)

Time: On admission and at the time of discharge, on average 2 months

Secondary Outcomes

Description: for assess other psychiatric symptoms

Measure: Change of SCL-90-R

Time: On admission and at the time of discharge, on average 2 months


No related HPO nodes (Using clinical trials)